[Answered] Action potentials occur in the a. cell body. b. synapse. c. neurotransmitters. d. ...

This topic contains a solution. Click here to go to the answer

Author Question: Action potentials occur in the a. cell body. b. synapse. c. neurotransmitters. d. ... (Read 98 times)

sam.t96

Hero Member
Posts: 570

on: Jun 20, 2018

Action potentials occur in the

a. cell body.
b. synapse.
c. neurotransmitters.
d. axon.

Question 2

Groups of interconnected neurons are referred to as

a. myelin sheaths.
b. potentiated somas.
c. neural circuits.
d. spreading activations.

Need homework help now?

Ask unlimited questions for free

Ask a Question

Marked as best answer by a Subject Expert

iman

Sr. Member
Posts: 334

Reply #1 on: Jun 20, 2018

Answer to Question 1

d

Answer to Question 2

c

sam.t96

Member
Posts: 570

Reply 2 on: Jun 20, 2018

Thanks for the timely response, appreciate it

TheDev123

Member
Posts: 332

Reply 3 on: Yesterday

YES! Correct, THANKS for helping me on my review

« previous next »

Did you know?

Though newer “smart” infusion pumps are increasingly becoming more sophisticated, they cannot prevent all programming and administration errors. Health care professionals that use smart infusion pumps must still practice the rights of medication administration and have other professionals double-check all high-risk infusions.

Did you know?

The word drug comes from the Dutch word droog (meaning "dry"). For centuries, most drugs came from dried plants, hence the name.

Did you know?

The average older adult in the United States takes five prescription drugs per day. Half of these drugs contain a sedative. Alcohol should therefore be avoided by most senior citizens because of the dangerous interactions between alcohol and sedatives.

Did you know?

Drugs are in development that may cure asthma and hay fever once and for all. They target leukotrienes, which are known to cause tightening of the air passages in the lungs and increase mucus productions in nasal passages.

Did you know?

Despite claims by manufacturers, the supplement known as Ginkgo biloba was shown in a study of more than 3,000 participants to be ineffective in reducing development of dementia and Alzheimer’s disease in older people.